NEBIUS GROUP NV(NASDAQ:NBIS) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to NBIS. NBIS was compared to 283 industry peers in the Software industry. No worries on liquidiy or solvency for NBIS as it has an excellent financial health rating, but there are worries on the profitability. NBIS is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year NBIS was profitable.

The reported net income has been mixed in the past 5 years: NBIS reported negative net income in multiple years.

Of the past 5 years NBIS 4 years had a positive operating cash flow.

1.2 Ratios

The Return On Assets of NBIS (-27.07%) is worse than 71.02% of its industry peers.

The Return On Equity of NBIS (-29.52%) is worse than 60.42% of its industry peers.

		Industry Rank	Sector Rank
ROA	-27.07%
ROE	-29.52%
ROIC	N/A

ROA(3y)-2.98%

ROA(5y)-1.4%

ROE(3y)0.05%

ROE(5y)0.41%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 36.15%, NBIS is doing worse than 75.97% of the companies in the same industry.

NBIS's Gross Margin has declined in the last couple of years.

The Profit Margin and Operating Margin are not available for NBIS so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	36.15%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-9.81%

GM growth 5Y-11.26%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NBIS does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for NBIS has been reduced compared to 1 year ago.

The number of shares outstanding for NBIS has been reduced compared to 5 years ago.

Compared to 1 year ago, NBIS has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 20.36 indicates that NBIS is not in any danger for bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 20.36, NBIS belongs to the top of the industry, outperforming 93.64% of the companies in the same industry.

NBIS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	20.36

ROIC/WACCN/A

WACC5.57%

2.3 Liquidity

NBIS has a Current Ratio of 9.64. This indicates that NBIS is financially healthy and has no problem in meeting its short term obligations.

With an excellent Current ratio value of 9.64, NBIS belongs to the best of the industry, outperforming 95.41% of the companies in the same industry.

A Quick Ratio of 9.64 indicates that NBIS has no problem at all paying its short term obligations.

With an excellent Quick ratio value of 9.64, NBIS belongs to the best of the industry, outperforming 95.41% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	9.64
Quick Ratio	9.64

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for NBIS have decreased strongly by -66.72% in the last year.

Measured over the past years, NBIS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -14.55% on average per year.

NBIS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -99.98%.

NBIS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.22% yearly.

EPS 1Y (TTM)-66.72%

EPS 3Y-33.2%

EPS 5Y-14.55%

EPS Q2Q%96.6%

Revenue 1Y (TTM)-99.98%

Revenue growth 3Y40.78%

Revenue growth 5Y36.22%

Sales Q2Q%-98.48%

3.2 Future

Based on estimates for the next years, NBIS will show a very negative growth in Earnings Per Share. The EPS will decrease by -60.16% on average per year.

NBIS is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -39.59% yearly.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3Y-98.15%

EPS Next 5Y-60.16%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3Y-65.76%

Revenue Next 5Y-39.59%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 1.97, which indicates a rather cheap valuation of NBIS.

98.23% of the companies in the same industry are more expensive than NBIS, based on the Price/Earnings ratio.

NBIS is valuated cheaply when we compare the Price/Earnings ratio to 26.03, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	1.97
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A cheap valuation may be justified as NBIS's earnings are expected to decrease with -98.15% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3Y-98.15%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for NBIS!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NEBIUS GROUP NV

NASDAQ:NBIS (5/21/2025, 6:09:00 PM)

After market: 38.1746 -0.75 (-1.92%)

38.92

-0.22 (-0.56%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)05-20 2025-05-20/bmo

Earnings (Next)07-28 2025-07-28

Inst Owners52.71%

Inst Owner ChangeN/A

Ins Owners3.63%

Ins Owner ChangeN/A

Market Cap9.18B

Analysts82.5

Price Target56.1 (44.14%)

Short Float %7.52%

Short Ratio1.35

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)N/A

EPS NQ rev (1m)0%

EPS NQ rev (3m)-5.09%

EPS NY rev (1m)0%

EPS NY rev (3m)-8.94%

Revenue NQ rev (1m)-20.23%

Revenue NQ rev (3m)-41.25%

Revenue NY rev (1m)-5.71%

Revenue NY rev (3m)-33.71%

Valuation

		Industry Rank	Sector Rank
PE	1.97
Fwd PE	N/A
P/S	71.18
P/FCF	N/A
P/OCF	N/A
P/B	2.82
P/tB	2.82
EV/EBITDA	N/A

EPS(TTM)19.75

EY50.75%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS0.55

BVpS13.82

TBVpS13.79

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-27.07%
ROE	-29.52%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	36.15%
FCFM	N/A

ROA(3y)-2.98%

ROA(5y)-1.4%

ROE(3y)0.05%

ROE(5y)0.41%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-9.81%

GM growth 5Y-11.26%

F-ScoreN/A

Asset Turnover0.04

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	9.64
Quick Ratio	9.64
Altman-Z	20.36

F-ScoreN/A

WACC5.57%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-66.72%

EPS 3Y-33.2%

EPS 5Y-14.55%

EPS Q2Q%96.6%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3Y-98.15%

EPS Next 5Y-60.16%

Revenue 1Y (TTM)-99.98%

Revenue growth 3Y40.78%

Revenue growth 5Y36.22%

Sales Q2Q%-98.48%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3Y-65.76%

Revenue Next 5Y-39.59%

EBIT growth 1Y-101.77%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year76.7%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

NEBIUS GROUP NV (NBIS) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens